Dr. David Mou, the CEO and former CMO of the telehealth psychiatry startup Cerebral, discusses guiding his company through DOJ investigations into controlled substance prescribing practices and market headwinds months after raising a $300M Series C at a $4.8B valuation. A Harvard-trained psychiatrist, Mou has a conversation about Cerebral's mission, building trust through clinical quality, and stepping up to navigate the company after its CEO was removed.